DNA-RNA synthesis inhibitor, Bleomycin hydrochloride, Purity ≥98%

Cat. No.: X24-08-YM099

DNA-RNA synthesis inhibitor, Bleomycin hydrochloride, Purity ≥98%

Synonym: 67763-87-5; 3-[[2-[2-[2-[[(2S,3R)-2-[[(2S,3S,4R)-4-[[(2S,3R)-2-[[6-Amino-2-[(1S)-3-amino-1-[[(2S)-2,3-diamino-3-oxopropyl]amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2R,3S,4S,5S,6S)-3-[(2R,3S,4S,5R,6R)-4-carbamoyloxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-(1H-imidazol-5-yl)propanoyl]amino]-3-hydroxy-2-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]ethyl]-1,3-thiazol-4-yl]-1,3-thiazole-4-carbonyl]amino]propyl-dimethylsulfanium; hydrochloride

  • CAS Number: 67763-87-5
  • Compound CID: 20832750
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Bleomycin hydrochloride is an effective DNA damage inhibitor, that has the ability to prevent the pathway of DNA damage by inhibiting DNA-RNA synthesis.
Molecular Weight
1451
Molecular Formula
C55H84ClN17O21S3
Form
Lyophilized powder
Purity
≥98%
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
Bleomycin hydrochloride is a DNA damage inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of Hodgkin’s disease, testicular cancer, and certain types of lymphoma and lung cancer.
Storage
Store at -20ºC, and keep desiccated.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0